What is the recommended initial evaluation and treatment for a patient with suspected gastric outlet obstruction?

Gastric Outlet Obstruction: Initial Evaluation and Treatment

For suspected gastric outlet obstruction, immediately assess the patient's functional status, life expectancy, and surgical candidacy through multidisciplinary evaluation, then proceed with imaging (CT scan preferred) and upper endoscopy to confirm the diagnosis and determine the underlying etiology 1.

Initial Diagnostic Approach

The evaluation must rapidly distinguish between malignant and benign causes while assessing the severity of obstruction:

Key Clinical Features to Identify

• Symptoms: Postprandial vomiting, epigastric pain, early satiety, and weight loss
• Timing: Malignant GOO typically presents in patients with known pancreatic, gastric, duodenal, ampullary, or biliary malignancies 1
• Nutritional status: Poor nutrition predicts worse outcomes with surgical intervention 1
• Functional status: Eastern Cooperative Oncology Group (ECOG) performance status and presence of ascites are critical prognostic indicators 1

Diagnostic Studies

• CT imaging: First-line to identify the level and cause of obstruction, assess for metastatic disease, and evaluate surgical candidacy
• Upper endoscopy: Confirms diagnosis, allows tissue sampling, and determines if the obstruction is amenable to endoscopic intervention
• Point-of-care ultrasound: Can demonstrate impaired gastric emptying and "target sign" when other imaging is unavailable 2

Treatment Algorithm Based on Etiology and Patient Factors

For Malignant Gastric Outlet Obstruction

The treatment choice hinges on three critical factors: life expectancy, surgical fitness, and functional status.

Patients with Life Expectancy >2 Months AND Good Functional Status AND Surgically Fit:

Surgical gastrojejunostomy (preferably laparoscopic) is the treatment of choice 1. This recommendation stems from the SUSTENT study showing that while enteral stents allow earlier food intake, surgical GJ provides superior long-term relief with fewer recurrent obstructions and re-interventions 1.

• Use laparoscopic approach over open surgery due to lower blood loss and shorter hospital stay 1
• Contraindications to surgery: Poor nutritional status, ascites, and poor functional status independently predict surgical failure 1

Patients with Life Expectancy <2 Months OR Poor Surgical Candidates:

Enteral stent placement is recommended 1. This provides faster symptom relief and earlier resumption of oral intake compared to surgery, which is appropriate when long-term durability is less critical.

Critical contraindications to enteral stenting 1:

• Multiple luminal obstructions
• Severely impaired gastric motility
• In these scenarios, place a venting gastrostomy instead 1

Emerging Alternative: EUS-Guided Gastroenterostomy

EUS-GE with lumen-apposing metal stent is an acceptable alternative to both surgical GJ and enteral stenting, depending on endoscopist experience 1. Recent data suggests advantages over enteral stents including reduced re-interventions and improved stent patency 3.

Important caveat: No dedicated FDA-approved devices currently exist for EUS-GE 1.

For Benign Gastric Outlet Obstruction

The approach differs significantly from malignant causes:

• Peptic ulcer disease: Medical management with proton pump inhibitors, followed by endoscopic balloon dilation if stricture develops 4
• Corrosive injury: Early definitive surgical intervention (pyloroplasty or Billroth I procedure) once diagnosis is confirmed; endoscopic balloon dilation may be attempted in suitable cases 5

Critical Decision-Making Framework

All treatment decisions must occur in a multidisciplinary setting including oncologists, surgeons, and endoscopists 1. The discussion should incorporate:

1. Prognosis assessment: Use the 2-month life expectancy threshold as a key decision point
2. Patient expectations and goals: Quality of life considerations are paramount given the poor prognosis associated with malignant GOO 1
3. Planned oncologic therapies: Establishing luminal patency may allow resumption of chemotherapy 1
4. Anatomic considerations: Assess for multiple obstructions or motility disorders that would preclude stenting

Common Pitfalls to Avoid

• Do not place enteral stents in patients with multiple obstructions or severe gastroparesis—they will fail and worsen patient suffering 1
• Avoid prolonged nasogastric tube use—it provides temporary decompression but significantly impairs quality of life 6
• Do not default to stenting in all poor surgical candidates—venting gastrostomy may be more appropriate for symptom control when oral intake cannot be restored 1
• Recognize that poor nutritional status, ascites, and poor functional status predict surgical failure—these patients need alternative approaches 1

Acute Management Considerations

For acute presentation with severe obstruction:

• Nasogastric decompression for immediate symptom relief
• Aggressive fluid resuscitation and electrolyte correction
• Early nutritional assessment to determine need for supplementation 6
• Pharmacologic symptom control: Opioids, antiemetics, and antisecretory agents, though evidence for their specific efficacy in GOO is limited 6